This article was originally published when we first saw the ads circulating, in April of 2019. The stock has since lost about 2/3 of its value, but we’re getting a lot more questions about it this week and the ad is circulating again, this time pitching it as a 50-cent “defense” stock that will double […]
The folks at RiskHedge are out with a new IPO-focused newsletter called IPO Insider ($2,997/yr is the promoted price), aiming to find “Hidden IPOs for Extreme Wealth” using Justin Spittler’s “SONAR” system for identifying the best IPO opportunities. Spittler used to write for a newsletter or two for Doug Casey’s firm, we’ve covered a few […]
High end monthly newsletter recommending IPOs, promoted as using a proprietary system to identify the best 10 or so newly public stocks to invest in during a given year. Spittler previously worked on International Speculator for Casey Research.
For some reason, the investment newsletter audience (and their publishers) find “anti-aging” pitches quite appealing… maybe it’s because so many of us are reaching those “golden years” and wondering how to extend them without pain or poverty. I’m not quite in the “core” demographic yet at 49, but I’ve got the knees and hips of […]
Let’s start with the bad news… we got quarterly updates this week from Charlotte’s Web (CWEB.TO, CWBHF) and II-VI (IIVI), both stocks I’ve bought fairly recently (IIVI just a few weeks ago, CWEB a few months ago), and those are both in the red. Neither one hit a stop loss yet, but what did we […]
Ian Wyatt is out with a new ad for a “urgent briefing” that will be taking place today about a “secret billionaire investment”… and while the briefing hasn’t happened yet, so we’re not sure what the pitch will be, odds are good that he’s going to keep the “insider shares” secret and dangle a subscription […]
This article was originally published on November 5, 2018, we’re getting lots of questions so we’re popping it to the top of the page for you but it has not been updated or revised — the ad being covered appears to be almost identical to the ad that was running in the fall of 2018. […]
Yesterday I started digging in to Matt McCall’s tease about a huge opportunity in Chinese biotech… and, as promised, today I’m finishing the job. The basic premise is that China is pushing to make biopharma a bigger part of its economy in both the current five-year plan and the “made in China 2025” plan, and […]
Matt McCall’s out with another high-priced promo letter that promises the potential for huge gains — this time, by finding the stocks that he thinks will benefit from China’s massive increase in health care spending in the years to come. The ad is for his Early Stage Investor, and he claims to be making a […]
Today I thought I’d answer a reader question about a teaser that’s of particular interest to me — not because it’s particularly heavily marketed, I haven’t even seen the original ad or article our reader cites, but because I like the topic. Here’s the question posted by Irregular bunion132 recently: In a recent piece entitled […]
Earnings season is clobbering me with news once again this week, so there’s a lot to share… I’ll start with the actual transactions I made today, and move on to look at a dozen other stocks I own or am watching… buckle up! We’ll start with the one that probably most of you can’t easily […]
Jason Stutman’s latest ad for his Technology and Opportunity newsletter ($39/yr, which means they’re really not making money on this unless they get you to upgrade to something else in the future) is yet one more attempt to get us excited because of the rising trend of 5G investment that he thinks will bring “skyrocketing […]
Today we’ve got a bit of a quickie for you, mostly just because the clues that were dropped were extremely limited… but it also happens to be a stock I’ve looked at before, so I thought it was worth taking a second look today. Paul Mampilly over the weekend was peddling his True Momentum service […]
One of half a dozen Paul Mampilly-connected newsletters at Banyan Hill, this one is a “trading service” that attempts to pick a couple midsize stocks each month that have “true momentum” (which seems to be a qualitative assessment of the business prospects, not a market momentum measure).
What have we learned about teaser ads over the past decade or so? A lot, I hope, but two lessons stand out: First, dates in teaser ads are often made up and don’t really represent meaningful “catalyst” events, they’re just a way to make you feel rushed and get you to pull out your credit […]
Geothermal is back! Paul Mampilly is circulating his “Ocean of Energy Under all 50 States” pitch once more, so it’s time to take another look. His ad is almost exactly the same as it was when we first covered it in March, 2017, but I’m sure the story must have changed a bit along the […]
Happy Friday! I’ve got another reading assignment for you today… the researcher behind the Dunning-Kruger effect posted an interesting article called “We Are All Confident Idiots” a couple years ago that just came to my attention (I think someone posted it on Twitter, but forgot to jot down the original source). Here’s a little excerpt, […]
This ad has been running for a week or so, since Crowdability hosted their “special presentation” to make the original pitch on October 23, and readers have been peppering me with questions… which makes sense, the idea of a “single stock retirement plan” is very compelling (Oxford Club has used it to pitch a different […]
Back to the Motley Fool we go… this week it’s the Motley Fool Canada that caught my attention, hinting at a recommendation they made a few months ago but still like now for their Hidden Gems Canada service. Here’s the lead-in for the ad, which I received just this morning… we start with the “fear […]
Small-cap stock picking service that recommends Canadian and US small-cap stocks (two “stock tips” per month).